Participant‐reported pain relief of 50% or greater · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Patient Global Impression of Change much or very much improved · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free between 4‐40 weeks · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who are seizure free between 4‐40 weeks (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients with an adverse event · Patients between three and 12 years old with clinical and EEG diagnosis of BECTS
The intervention showed no clear difference in proportion of patients with an adverse event (low certainty).
1 finding from 1 review
Intervention not reported
Changes in cognitive function · Patients between three and 12 years old with clinical and EEG diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 28 weeks · Patients between five and 15 years old with a diagnosis of BECTS
The intervention showed no clear difference in proportion of patients who are seizure free at 28 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (28 weeks trial period) · Patients between five and 15 years old with a diagnosis of BECTS
The intervention showed no clear difference in proportion of patients who discontinued treatment due to adverse… (low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients with an adverse event: · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients with a particular or serious adverse event: 1. Somnolence 2. Rash · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Changes in cognitive function testing from baseline (28 weeks trial period) · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 3 months · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher proportion of patients who are seizure free at 3 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 6 months · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher proportion of patients who are seizure free at 6 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Time to first seizure after randomisation · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher time to first seizure after randomisation (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who had seizure remission in the last 9 months of the study · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who had seizure remission in the last 9… (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (over 6 months trial period) · Patients between three and 10 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients with an adverse event · Patients between three and 10 years old with a diagnosis of BECTS
The intervention showed no clear difference in proportion of patients with an adverse event (moderate certainty).
1 finding from 1 review
Intervention not reported
Changes in cognitive function · Patients between three and 10 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (96 weeks trial period) · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who discontinued treatment due to adverse… (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who reported adverse events · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who reported adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients with a particular or serious adverse event: 1. Vertigo 2. Headache 3. Somnolence 4. Nausea/Vomiting 5. Tremor 6. Fatigue · Patients with a clinical and EEG diagnosis of BECTS
1 finding from 1 review